Rep. DeLauro’s FDA Focus: “Restore” Oversight, Increase Budget
This article was originally published in The Tan Sheet
Executive Summary
Rep. Rosa DeLauro (D-Conn.), poised to take the helm of the House subcommittee with oversight of FDA's budget, hopes to increase agency funding, but not without the tradeoff of enhanced congressional supervision of how FDA performs its duties
You may also be interested in...
Democrats Expected To Put Supplement, Drug Regulation Under Microscope
Increased scrutiny of issues including the safety of dietary supplements and phenylephrine efficacy is likely as senior Democrats move into leadership roles on Congressional committees following the 2006 midterm elections
DeLauro Bill Calls For FDA Plan B Workshop To Discuss Sub-18 Data
A bill to be filed Sept. 26 by Rep. Rosa DeLauro (D-Conn.) would require that FDA hold a scientific workshop to examine data on the use of Plan B emergency contraceptive in women under age 18
Study Shows No Death, MI Advantages For Stenting Over Medical Therapy
Results form the 2,287-patient COURAGE trial presented the American College of Cardiology meeting should give physicians more to think about before moving forward with percutaneous coronary intervention in stable heart disease patients, researchers say.